Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients R. Cantón, N. Cobos,

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Development of resistance in Pseudomonas aeruginosa obtained from patients with cystic fibrosis at different times F.B. Spencker, L. Staber, T. Lietz,

Patterns of delays in diagnosis amongst patients with smear-positive pulmonary tuberculosis at a teaching hospital in Turkey E. Okur, A. Yilmaz, A. Saygi,

Rapid single-nucleotide polymorphism-based identification of clonal Pseudomonas aeruginosa isolates from patients with cystic fibrosis by the use of real-time.

L. Boyanova Clinical Microbiology and Infection

R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, T

M. A. Montes-Cano, C. de la Horra, F. J. Dapena, I. Mateos, V

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

R. Colodner, O. Nitzan, B. Chazan, H. Edelstein, R. Raz

Migrant health—a cause for concern?

E. Bronska, J. Kalmusova, O. Dzupova, V. Maresova, P. Kriz, J. Benes

Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Virological tools to diagnose and monitor hepatitis C virus infection

Public health microbiology, a challenge for Europe

R. Cantón Clinical Microbiology and Infection

Nosocomial spread of Pseudomonas aeruginosa producing the metallo-β-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications

P. Nordmann, L. Poirel Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

Rapid single-nucleotide polymorphism-based identification of clonal Pseudomonas aeruginosa isolates from patients with cystic fibrosis by the use of real-time.

Surveillance of Legionnaires’ disease in Austria

Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain J.-M. Aguado, C. Lumbreras, D.

Vector control: a cornerstone in the malaria elimination campaign

D. Worlitzsch, C. Rintelen, K. Böhm, B. Wollschläger, N. Merkel, M

F.R. Gómez, E.P. de la Llave, J.M. García-Lechuz Moya

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Oral versus intravenous therapy in the treatment of systemic mycosis

A. Oliver, A. Mena Clinical Microbiology and Infection

Training for the infectious diseases speciality in Norway

Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemia S.-C. Kuo, Y.-T. Lee,

F. Bittar, J.-M. Rolain Clinical Microbiology and Infection

Significance of human β-defensins in the epithelial lining fluid of patients with chronic lower respiratory tract infections S. Yanagi, J. Ashitani,

H. Yongfeng, Y. Fan, D. Jie, Y. Jian, Z. Ting, S. Lilian, Q. Jin

Elements of design: the knowledge on which we build

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Levofloxacin in the treatment of ventilator-associated pneumonia

Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose P. Savard, T.M. Perl Clinical Microbiology.

Metagenomics and probiotics

K.J. Psoter, A.J. De Roos, J. Wakefield, J. Mayer, M. Rosenfeld

B. Sádaba, J.R. Azanza, M.A. Campanero, E. García-Quetglas

Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009 Yolanda P. Lillquist,

T.M. File Clinical Microbiology and Infection

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Current experience in treating invasive zygomycosis with posaconazole

Antimicrobial drug development – the past, the present, and the future

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

An after-hours clinical liaison blood culture service—is it worth it?

R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, T

Statin use and clinical outcomes among pneumonia patients

Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

B.A. Cunha Clinical Microbiology and Infection

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

B. Martha, D. Croisier, A. Fanton, K. Astruc, L. Piroth, F. Huet, P

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience C.R.

Presentation transcript:

Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients R. Cantón, N. Cobos, J. de Gracia, F. Baquero, J. Honorato, S. Gartner, A. Alvarez, A. Salcedo, A. Oliver, E. García-Quetglas Clinical Microbiology and Infection Volume 11, Issue 9, Pages 690-703 (September 2005) DOI: 10.1111/j.1469-0691.2005.01217.x Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Summary of the sequence of colonisation and infection events involving Pseudomonas aeruginosa in cystic fibrosis patients, and the theoretical objectives of antimicrobial treatment at each stage. Clinical Microbiology and Infection 2005 11, 690-703DOI: (10.1111/j.1469-0691.2005.01217.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions